Vaccines and Immunotherapy — Scientific Principles

Scientific Principles

Vaccines and immunotherapy are critical biomedical interventions that leverage the body's immune system to combat diseases. Vaccines are primarily prophylactic, meaning they prevent infectious diseases by introducing weakened, inactivated, or partial components of a pathogen to 'train' the immune system.

This training leads to the production of antibodies and memory cells, enabling a rapid and effective response upon future exposure to the actual pathogen. Key vaccine types include live attenuated (e.g.

, MMR), inactivated (e.g., Covaxin), subunit (e.g., Hepatitis B), mRNA (e.g., Pfizer-BioNTech), and viral vector (e.g., Covishield) vaccines, each with distinct mechanisms, advantages, and storage requirements.

The development of mRNA and viral vector platforms during the COVID-19 pandemic showcased rapid innovation and adaptability in vaccinology.

Immunotherapy, conversely, is largely therapeutic, aiming to treat existing diseases, predominantly cancer, by modulating or enhancing the patient's own immune response. Cancer cells often evade immune detection, and immunotherapy strategies seek to overcome this.

Major approaches include monoclonal antibodies (mAbs) like Rituximab and Pembrolizumab, which target specific cancer cell markers or immune checkpoints; immune checkpoint inhibitors that 'release the brakes' on T cells; and advanced cell therapies like CAR-T cell therapy, where a patient's T cells are genetically engineered to specifically recognize and destroy cancer cells.

While offering revolutionary treatment options, immunotherapies can have significant side effects, such as cytokine release syndrome, and pose challenges related to cost and access. India plays a crucial role in global vaccine manufacturing, with companies like Serum Institute of India and Bharat Biotech being major producers.

The country's regulatory framework, governed by CDSCO under the Drugs and Cosmetics Act, 1940, ensures the safety and efficacy of these biological products. Ethical considerations like informed consent, equitable access, and pharmacovigilance are paramount in the development and deployment of both vaccines and immunotherapies.

Important Differences

vs Vaccine Types

Aspect	This Topic	Vaccine Types
Mechanism	Live Attenuated	Inactivated
Mechanism Detail	Weakened live pathogen replicates, mimics natural infection.	Killed whole pathogen, cannot replicate.
Key Vaccine Examples	MMR, OPV, BCG, Varicella, Yellow Fever	IPV, Hepatitis A, Rabies, Covaxin
Advantages	Strong, long-lasting immunity; cellular & humoral response.	Safe for immunocompromised; stable.
Disadvantages	Risk of reversion (rare); not for immunocompromised; cold-chain.	Weaker response; multiple doses; poor cellular immunity; large pathogen handling.
Storage/Temperature	2-8°C or -20°C (e.g., Measles)	2-8°C
Typical Immune Response	Strong, broad, long-lasting (cellular & humoral)	Primarily humoral (antibodies), less cellular

Understanding the distinct characteristics of different vaccine platforms is crucial for UPSC aspirants. Live attenuated vaccines offer robust, long-lasting immunity but carry risks for vulnerable populations and require stringent cold chains. Inactivated and subunit vaccines are safer but often require multiple doses and adjuvants for a strong response. The newer mRNA and viral vector technologies, exemplified by COVID-19 vaccines, offer rapid development and strong immune responses, though mRNA vaccines pose unique cold-chain challenges. Each type represents a trade-off between safety, immunogenicity, manufacturing complexity, and logistical requirements, influencing their suitability for different pathogens and public health contexts.

vs Prophylactic vs. Therapeutic Vaccines

Aspect	This Topic	Prophylactic vs. Therapeutic Vaccines
Primary Goal	Prophylactic Vaccines	Therapeutic Vaccines
Goal Detail	Prevent disease before exposure.	Treat an existing disease.
Timing of Administration	Before infection/disease onset.	After infection/disease diagnosis.
Target Disease	Infectious diseases (e.g., polio, measles, influenza).	Chronic infections (e.g., HIV, HPV-related cancers), cancer.
Mechanism	Prime naive immune system to recognize future threats.	Boost or redirect existing immune response against diseased cells.
Immune Response Focus	Generate protective antibodies and memory cells.	Enhance cytotoxic T-cell activity, overcome immune evasion.
Examples	MMR, DTaP, COVID-19 vaccines (Pfizer, Moderna, Covaxin).	Sipuleucel-T (prostate cancer), HPV therapeutic vaccines (under development).
Development Stage	Well-established, many approved.	Emerging field, many in clinical trials.

The fundamental distinction between prophylactic and therapeutic vaccines lies in their timing and objective. Prophylactic vaccines are preventive tools, preparing the immune system to ward off future infections, forming the backbone of public health immunization programs. Therapeutic vaccines, conversely, are treatment modalities, aiming to activate or redirect the immune system to combat an already established disease, such as cancer or chronic viral infections. While prophylactic vaccines have a long history of success, therapeutic vaccines represent a cutting-edge area of research, particularly in oncology, seeking to harness the immune system for curative purposes.